Johnson & Johnson to Provide Webcast Presentation of Tapentadol Phase 3 Clinical Data Presented at American Pain Society's Annual Meeting
Posted on Wed, May. 07, 2008
By Johnson & Johnson
NEW BRUNSWICK, N.J., May 7 --
Johnson & Johnson
will provide a pre-recorded webcast for financial analysts on Friday, May 9 at
4:00 p.m. (Eastern Time) to coincide with the American Pain Society's (APS)
annual meeting in Tampa, Fla. Phase 3 clinical data presentations on
investigational tapentadol immediate release (IR), a novel centrally acting
oral analgesic, will be presented for the first time at APS.
A pre-recorded Webcast, with the lead tapentadol researchers, will be made
available concurrent to the data presentations being made during the poster
session at APS. Pre-registration is not required to view the webcast/podcast.
The presentation will provide an overview on tapentadol IR and review data
from the following clinical posters:
-- Efficacy of Tapentadol Immediate Release in Patients With Pain After
Bunionectomy
-- Analgesic Efficacy of Tapentadol Immediate Release in Patients With
Pain From End-Stage Joint Disease
-- Tapentadol Immediate Release is Associated With Improved
Gastrointestinal Tolerability Compared With Oxycodone Immediate Release
Over 90 Days in Patients With Lower Back or Osteoarthritis Pain The webcast/podcast and replay can be accessed by clicking on
"Webcasts/Presentations" in the Investor Relations section of the Company's
website at http://www.jnj.com.
SOURCE Johnson & Johnson
Investors - Louise Mehrotra, +1-732-524-6491, or Lesley Fishman, +1-732-524-3922,
Join the discussion
The Miami Herald is pleased to provide this opportunity to share information, experiences and observations about what's in the news. Some of the comments may be reprinted elsewhere in the site or in the newspaper. We encourage lively, open debate on the issues of the day, and ask that you refrain from personal comments and remarks that are off point. In order to post comments, you must be a registered user of MiamiHerald.com. Your username will show along with the comments you post. Not a registered user? It's Free!
Register here. Thank you for taking the time to offer your thoughts.
